AAAAAA

   
Results: 1-21 |
Results: 21
POLYNUCLEOTIDE IMMUNIZATION OF NONHUMAN-PRIMATES AGAINST CARCINOEMBRYONIC ANTIGEN
Authors: CONRY RM WHITE SA FULTZ PN KHAZAELI MB STRONG TV ALLEN KO BARLOW DL MOORE SE COAN PN DAVIS I CURIEL DT LOBUGLIO AF
Citation: Rm. Conry et al., POLYNUCLEOTIDE IMMUNIZATION OF NONHUMAN-PRIMATES AGAINST CARCINOEMBRYONIC ANTIGEN, Clinical cancer research, 4(11), 1998, pp. 2903-2912
HUMORAL AND CELLULAR IMMUNE-RESPONSES OF DOGS IMMUNIZED WITH A NUCLEIC-ACID VACCINE ENCODING HUMAN CARCINOEMBRYONIC ANTIGEN
Authors: SMITH BF BAKER HJ CURIEL DT JIANG W CONRY RM
Citation: Bf. Smith et al., HUMORAL AND CELLULAR IMMUNE-RESPONSES OF DOGS IMMUNIZED WITH A NUCLEIC-ACID VACCINE ENCODING HUMAN CARCINOEMBRYONIC ANTIGEN, Gene therapy, 5(7), 1998, pp. 865-868
EFFECTS OF A NOVEL PURINE NUCLEOSIDE PHOSPHORYLASE INHIBITOR, BCX-34,ON ACTIVATION AND PROLIFERATION OF NORMAL HUMAN LYMPHOID-CELLS
Authors: CONRY RM BANTIA S TURNER HS BARLOW DL ALLEN KO LOBUGLIO AF MONTGOMERY JA WALSH GM
Citation: Rm. Conry et al., EFFECTS OF A NOVEL PURINE NUCLEOSIDE PHOSPHORYLASE INHIBITOR, BCX-34,ON ACTIVATION AND PROLIFERATION OF NORMAL HUMAN LYMPHOID-CELLS, Immunopharmacology, 40(1), 1998, pp. 1-9
INCORPORATION OF BETA-GLOBIN UNTRANSLATED REGIONS INTO A SINDBIS VIRUS VECTOR FOR AUGMENTATION OF HETEROLOGOUS MESSENGER-RNA EXPRESSION
Authors: STRONG TV HAMPTON TA LOURO I BILBAO G CONRY RM CURIEL DT
Citation: Tv. Strong et al., INCORPORATION OF BETA-GLOBIN UNTRANSLATED REGIONS INTO A SINDBIS VIRUS VECTOR FOR AUGMENTATION OF HETEROLOGOUS MESSENGER-RNA EXPRESSION, Gene therapy, 4(6), 1997, pp. 624-627
IMMUNIZATION WITH A PLASMID EXPRESSING PNEUMOCOCCAL SURFACE PROTEIN-A(PSPA) CAN ELICIT PROTECTION AGAINST FATAL INFECTION WITH STREPTOCOCCUS-PNEUMONIAE
Authors: MCDANIEL LS LOECHEL F BENEDICT C GREENWAY T BRILES DE CONRY RM CURIE DT
Citation: Ls. Mcdaniel et al., IMMUNIZATION WITH A PLASMID EXPRESSING PNEUMOCOCCAL SURFACE PROTEIN-A(PSPA) CAN ELICIT PROTECTION AGAINST FATAL INFECTION WITH STREPTOCOCCUS-PNEUMONIAE, Gene therapy, 4(4), 1997, pp. 375-377
PHASE-I TRIAL OF POLYNUCLEOTIDE IMMUNIZATION TO CARCINOEMBRYONIC ANTIGEN IN PATIENTS WITH METASTATIC COLORECTAL-CANCER
Authors: CONRY RM STRONG TV WHITE SA KHAZAELI MB LOBUGLIO AF CURIEL DT
Citation: Rm. Conry et al., PHASE-I TRIAL OF POLYNUCLEOTIDE IMMUNIZATION TO CARCINOEMBRYONIC ANTIGEN IN PATIENTS WITH METASTATIC COLORECTAL-CANCER, Cancer gene therapy, 4(6), 1997, pp. 126-126
SEROLOGICAL IDENTIFICATION OF THE MURINE ENDOGENOUS LEUKEMIA PROVIRALENVELOPE PROTEIN AS A TUMOR-ANTIGEN
Authors: HAMPTON T SUMEREL LS KHAZAELI MB CONRY RM LOBUGLIO A CURIEL DT STRONG TV
Citation: T. Hampton et al., SEROLOGICAL IDENTIFICATION OF THE MURINE ENDOGENOUS LEUKEMIA PROVIRALENVELOPE PROTEIN AS A TUMOR-ANTIGEN, Cancer gene therapy, 4(6), 1997, pp. 138-138
PHASE IA TRIAL OF A POLYNUCLEOTIDE ANTITUMOR IMMUNIZATION TO HUMAN CARCINOEMBRYONIC ANTIGEN IN PATIENTS WITH METASTATIC COLORECTAL-CANCER
Authors: CONRY RM LOBUGLIO AF CURIEL DT
Citation: Rm. Conry et al., PHASE IA TRIAL OF A POLYNUCLEOTIDE ANTITUMOR IMMUNIZATION TO HUMAN CARCINOEMBRYONIC ANTIGEN IN PATIENTS WITH METASTATIC COLORECTAL-CANCER, Human gene therapy, 7(6), 1996, pp. 755-772
SELECTED STRATEGIES TO AUGMENT POLYNUCLEOTIDE IMMUNIZATION
Authors: CONRY RM WIDERA G LOBUGLIO AF FULLER JT MOORE SE BARLOW DL TURNER J CURIEL DT
Citation: Rm. Conry et al., SELECTED STRATEGIES TO AUGMENT POLYNUCLEOTIDE IMMUNIZATION, Gene therapy, 3(1), 1996, pp. 67-74
POLYNUCLEOTIDE-MEDIATED IMMUNIZATION THERAPY OF CANCER
Authors: CONRY RM LOBUGLIO AF CURIEL DT
Citation: Rm. Conry et al., POLYNUCLEOTIDE-MEDIATED IMMUNIZATION THERAPY OF CANCER, Seminars in oncology, 23(1), 1996, pp. 135-147
PHASE-I TRIAL OF AN ANTI-CD19 DEGLYCOSYLATED RICIN-A CHAIN IMMUNOTOXIN IN NON-HODGKINS-LYMPHOMA - EFFECT OF AN INTENSIVE SCHEDULE OF ADMINISTRATION
Authors: CONRY RM KHAZAELI MB SALEH MN GHETIE V VITETTA ES LIU TP LOBUGLIO AF
Citation: Rm. Conry et al., PHASE-I TRIAL OF AN ANTI-CD19 DEGLYCOSYLATED RICIN-A CHAIN IMMUNOTOXIN IN NON-HODGKINS-LYMPHOMA - EFFECT OF AN INTENSIVE SCHEDULE OF ADMINISTRATION, Journal of immunotherapy with emphasis on tumor immunology, 18(4), 1995, pp. 231-241
A CARCINOEMBRYONIC ANTIGEN POLYNUCLEOTIDE VACCINE HAS IN-VIVO ANTITUMOR-ACTIVITY
Authors: CONRY RM LOBUGLIO AF LOECHEL F MOORE SE SUMEREL LA BARLOW DL CURIEL DT
Citation: Rm. Conry et al., A CARCINOEMBRYONIC ANTIGEN POLYNUCLEOTIDE VACCINE HAS IN-VIVO ANTITUMOR-ACTIVITY, Gene therapy, 2(1), 1995, pp. 59-65
A CARCINOEMBRYONIC ANTIGEN POLYNUCLEOTIDE VACCINE FOR HUMAN CLINICAL USE
Authors: CONRY RM LOBUGLIO AF LOECHEL F MOORE SE SUMEREL LA BARLOW DL PIKE J CURIEL DT
Citation: Rm. Conry et al., A CARCINOEMBRYONIC ANTIGEN POLYNUCLEOTIDE VACCINE FOR HUMAN CLINICAL USE, Cancer gene therapy, 2(1), 1995, pp. 33-38
A SINDBIS VIRUS MESSENGER-RNA POLYNUCLEOTIDE VECTOR ACHIEVES PROLONGED AND HIGH-LEVEL HETEROLOGOUS GENE-EXPRESSION IN-VIVO
Authors: JOHANNING FW CONRY RM LOBUGLIO AF WRIGHT M SUMEREL LA PIKE MJ CURIEL DT
Citation: Fw. Johanning et al., A SINDBIS VIRUS MESSENGER-RNA POLYNUCLEOTIDE VECTOR ACHIEVES PROLONGED AND HIGH-LEVEL HETEROLOGOUS GENE-EXPRESSION IN-VIVO, Nucleic acids research, 23(9), 1995, pp. 1495-1501
CHARACTERIZATION OF A MESSENGER-RNA POLYNUCLEOTIDE VACCINE VECTOR
Authors: CONRY RM LOBUGLIO AF WRIGHT M SUMEREL L PIKE MJ FENG JN BENJAMIN R LU D CURIEL DT
Citation: Rm. Conry et al., CHARACTERIZATION OF A MESSENGER-RNA POLYNUCLEOTIDE VACCINE VECTOR, Cancer research, 55(7), 1995, pp. 1397-1400
HUMAN IMMUNE-RESPONSE TO MONOCLONAL-ANTIBODIES
Authors: KHAZAELI MB CONRY RM LOBUGLIO AF
Citation: Mb. Khazaeli et al., HUMAN IMMUNE-RESPONSE TO MONOCLONAL-ANTIBODIES, Journal of immunotherapy with emphasis on tumor immunology, 15(1), 1994, pp. 42-52
INTRACELLULAR SINGLE-CHAIN ANTIBODY-DIRECTED AGAINST ERBB2 DOWN-REGULATES CELL-SURFACE ERBB2 AND EXHIBITS A SELECTIVE ANTIPROLIFERATIVE EFFECT IN ERBB2 OVEREXPRESSING CANCER CELL-LINES
Authors: DESHANE J LOECHEL F CONRY RM SIEGAL GP KING CR CURIEL DT
Citation: J. Deshane et al., INTRACELLULAR SINGLE-CHAIN ANTIBODY-DIRECTED AGAINST ERBB2 DOWN-REGULATES CELL-SURFACE ERBB2 AND EXHIBITS A SELECTIVE ANTIPROLIFERATIVE EFFECT IN ERBB2 OVEREXPRESSING CANCER CELL-LINES, Gene therapy, 1(5), 1994, pp. 332-337
OPTIMIZATION OF METHODS TO ACHIEVE MESSENGER-RNA-MEDIATED TRANSFECTION OF TUMOR-CELLS IN-VITRO AND IN-VIVO EMPLOYING CATIONIC LIPOSOME VECTORS
Authors: LU D BENJAMIN R KIM M CONRY RM CURIEL DT
Citation: D. Lu et al., OPTIMIZATION OF METHODS TO ACHIEVE MESSENGER-RNA-MEDIATED TRANSFECTION OF TUMOR-CELLS IN-VITRO AND IN-VIVO EMPLOYING CATIONIC LIPOSOME VECTORS, Cancer gene therapy, 1(4), 1994, pp. 245-252
IMMUNE-RESPONSE TO A CARCINOEMBRYONIC ANTIGEN POLYNUCLEOTIDE VACCINE
Authors: CONRY RM LOBUGLIO AF KANTOR J SCHLOM J LOECHEL F MOORE SE SUMEREL LA BARLOW DL ABRAMS S CURIEL DT
Citation: Rm. Conry et al., IMMUNE-RESPONSE TO A CARCINOEMBRYONIC ANTIGEN POLYNUCLEOTIDE VACCINE, Cancer research, 54(5), 1994, pp. 1164-1168
CHARACTERIZATION OF POLIOVIRUS REPLICONS ENCODING CARCINOEMBRYONIC ANTIGEN
Authors: ANSARDI DC MOLDOVEANU Z PORTER DC WALKER DE CONRY RM LOBUGLIO AF MCPHERSON S MORROW CD
Citation: Dc. Ansardi et al., CHARACTERIZATION OF POLIOVIRUS REPLICONS ENCODING CARCINOEMBRYONIC ANTIGEN, Cancer research, 54(24), 1994, pp. 6359-6364
THE IN-VITRO IMMUNOSUPPRESSIVE EFFECTS OF A NOVEL PURINE NUCLEOSIDE PHOSPHORYLASE INHIBITOR IN MAN
Authors: CONRY RM TURNER HS WALSH GM LOBUGLIO AF
Citation: Rm. Conry et al., THE IN-VITRO IMMUNOSUPPRESSIVE EFFECTS OF A NOVEL PURINE NUCLEOSIDE PHOSPHORYLASE INHIBITOR IN MAN, Clinical research, 41(4), 1993, pp. 10000796-10000796
Risultati: 1-21 |